Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited

APNHF

$8.90

Updated: 24/09/2026, 08:37:32

Market Cap
$3.95B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
ZA
Stock valuation chart
One-year closing share-price history for APNHF
Company Profile

Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities are structured into two main divisions: Commercial Pharmaceuticals and Manufacturing. Under its Anaesthetics portfolio, Aspen offers diverse products such as general anesthetics, muscle relaxants, and topical agents. Its Thrombosis brand is dedicated to a variety of injectable anticoagulants, with an emphasis on low molecular weight heparins, Xa inhibitors, and heparin derivatives. Additionally, Aspen provides a range of branded consumer, prescription, and over-the-counter medications through regional brands. These include Circadin (for sleep management), Foxair (for respiratory conditions), Maltofer (an iron supplement), Mybulen (a painkiller), and Zyloric (which controls uric acid production). Beyond its proprietary offerings, the company also manufactures and supplies active pharmaceutical ingredients (APIs) and finished dosage form products to external clients. Founded in 1850, Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.

USD
OTC
CEO: Stephen Bradley Saad
Employees: 9,557
https://www.aspenpharma.com
Asset Summaries
Latest generated summaries for APNHF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for APNHF.
Share price
$8.90
Market cap
$3.95B
Exchange
OTC
Currency
USD
CEO
Stephen Bradley Saad
Employees
9,557
IPO date
29/04/2010
Beta
0.335
Last dividend
$0.00
Day range
$8.80 – $8.90
52-week range
$6.23 – $8.90
1-day performance
0.00%
1-year performance
42.79%
Current drawdown (1Y)
0.00%
CIK
N/A
CUSIP
N/A
ISIN
ZAE000066692
Created
07/12/2025, 02:06:54
Last update
24/09/2026, 08:37:32

Track Aspen Pharmacare Holdings Limited with an AI analyst

See which prediction-market events move APNHF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to APNHF from your Railway `news_articles` table.

No news found for this symbol.